Quotes 5-day view Delayed Nasdaq
09/25/2020
09/28/2020
09/29/2020
09/30/2020
10/01/2020
Date
35.43(c)
36.07(c)
35.38(c)
35.92(c)
35.87 Last
5 955 371
5 901 611
5 079 568
6 679 235
4 808 557 Volume
+1.14% +1.81% -1.91% +1.53% -0.14% Change
Sales 2020
139 B - -
Net income 2020
641 M - -
Net Debt 2020
15 295 M - -
P/E ratio 2020
49,9x
Yield 2020
5,19%
Sales 2021
143 B - -
Net income 2021
3 509 M - -
Net Debt 2021
13 317 M - -
P/E ratio 2021
8,90x
Yield 2021
5,30%
Capitalization
31 126 M 31 126 M -
EV / Sales 2020
0,33x
EV / Sales 2021
0,31x
Nbr of Employees
287 000
Free-Float
61,4%
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows:
- retail distribution (83.4%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.1% of net sales) and International (9.9%). At the end of August 2019, the activity is ensured through 13,882 outlets (including 9,277 in the United...
Notations Surperformance© of Walgreens Boots Alliance, Inc.
Trading Rating : Investor Rating :
All news about WALGREENS BOOTS ALLIANCE, INC.
News in other languages on WALGREENS BOOTS ALLIANCE, INC.
Chart WALGREENS BOOTS ALLIANCE, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends WALGREENS BOOTS ALLIANCE, INC.
Short Term Mid-Term Long Term Trends Neutral Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
22
Average target price
41,25 $
Last Close Price
35,92 $
Spread / Highest target
33,6%
Spread / Average Target
14,8%
Spread / Lowest Target
3,01%
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
